rewirebio.iobenchmarks
Source

Comprehensive assessment of computational algorithms in predicting cancer driver mutations

Genome Biology 21:43, published 2020-02-20; PMC7033911 full-text XML · Peer-reviewed

DOI: 10.1186/s13059-020-01954-z

What this source contributed

Records in this release that cite this source. A record can cite several sources.

Results

Values as the source printed them. Compare results only under compatible protocols, datasets and metrics.

Model or configurationMetricValueDatasetEvaluation
CADD (Chen et al. 2020)Accuracy (cell viability drivers versus neutral, median-score threshold)0.59 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CADD on cell viability drivers versus neutral, median-score threshold (Chen et al. 2020)
CADD (Chen et al. 2020)Negative predictive value (cell viability drivers versus neutral, median-score threshold)0.59 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CADD on cell viability drivers versus neutral, median-score threshold (Chen et al. 2020)
CADD (Chen et al. 2020)Precision (cell viability drivers versus neutral, median-score threshold)0.59 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CADD on cell viability drivers versus neutral, median-score threshold (Chen et al. 2020)
CADD (Chen et al. 2020)Recall (cell viability drivers versus neutral, median-score threshold)0.59 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CADD on cell viability drivers versus neutral, median-score threshold (Chen et al. 2020)
CADD (Chen et al. 2020)Specificity (cell viability drivers versus neutral, median-score threshold)0.59 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CADD on cell viability drivers versus neutral, median-score threshold (Chen et al. 2020)
CADD (Chen et al. 2020)Accuracy (OncoKB benchmark (positive set not stated), median-score threshold)0.64 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CADD on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CADD (Chen et al. 2020)Negative predictive value (OncoKB benchmark (positive set not stated), median-score threshold)0.64 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CADD on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CADD (Chen et al. 2020)Precision (OncoKB benchmark (positive set not stated), median-score threshold)0.64 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CADD on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CADD (Chen et al. 2020)Recall (OncoKB benchmark (positive set not stated), median-score threshold)0.64 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CADD on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CADD (Chen et al. 2020)Specificity (OncoKB benchmark (positive set not stated), median-score threshold)0.64 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CADD on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CanDrA (Chen et al. 2020)Accuracy (cell viability drivers versus neutral, default categorical calls)0.59 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CanDrA on cell viability drivers versus neutral, default categorical calls (Chen et al. 2020)
CanDrA (Chen et al. 2020)Negative predictive value (cell viability drivers versus neutral, default categorical calls)0.69 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CanDrA on cell viability drivers versus neutral, default categorical calls (Chen et al. 2020)
CanDrA (Chen et al. 2020)Precision (cell viability drivers versus neutral, default categorical calls)0.56 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CanDrA on cell viability drivers versus neutral, default categorical calls (Chen et al. 2020)
CanDrA (Chen et al. 2020)Recall (cell viability drivers versus neutral, default categorical calls)0.87 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CanDrA on cell viability drivers versus neutral, default categorical calls (Chen et al. 2020)
CanDrA (Chen et al. 2020)Specificity (cell viability drivers versus neutral, default categorical calls)0.30 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CanDrA on cell viability drivers versus neutral, default categorical calls (Chen et al. 2020)
CanDrA (Chen et al. 2020)Accuracy (cell viability drivers versus neutral, median-score threshold)0.67 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CanDrA on cell viability drivers versus neutral, median-score threshold (Chen et al. 2020)
CanDrA (Chen et al. 2020)Negative predictive value (cell viability drivers versus neutral, median-score threshold)0.67 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CanDrA on cell viability drivers versus neutral, median-score threshold (Chen et al. 2020)
CanDrA (Chen et al. 2020)Precision (cell viability drivers versus neutral, median-score threshold)0.67 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CanDrA on cell viability drivers versus neutral, median-score threshold (Chen et al. 2020)
CanDrA (Chen et al. 2020)Recall (cell viability drivers versus neutral, median-score threshold)0.67 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CanDrA on cell viability drivers versus neutral, median-score threshold (Chen et al. 2020)
CanDrA (Chen et al. 2020)Specificity (cell viability drivers versus neutral, median-score threshold)0.67 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CanDrA on cell viability drivers versus neutral, median-score threshold (Chen et al. 2020)
CanDrA (Chen et al. 2020)Accuracy (OncoKB benchmark (positive set not stated), default categorical calls)0.49 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CanDrA on OncoKB benchmark (positive set not stated), default categorical calls (Chen et al. 2020)
CanDrA (Chen et al. 2020)Negative predictive value (OncoKB benchmark (positive set not stated), default categorical calls)0.46 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CanDrA on OncoKB benchmark (positive set not stated), default categorical calls (Chen et al. 2020)
CanDrA (Chen et al. 2020)Precision (OncoKB benchmark (positive set not stated), default categorical calls)0.49 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CanDrA on OncoKB benchmark (positive set not stated), default categorical calls (Chen et al. 2020)
CanDrA (Chen et al. 2020)Recall (OncoKB benchmark (positive set not stated), default categorical calls)0.80 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CanDrA on OncoKB benchmark (positive set not stated), default categorical calls (Chen et al. 2020)
CanDrA (Chen et al. 2020)Specificity (OncoKB benchmark (positive set not stated), default categorical calls)0.17 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CanDrA on OncoKB benchmark (positive set not stated), default categorical calls (Chen et al. 2020)
CanDrA (Chen et al. 2020)Accuracy (OncoKB benchmark (positive set not stated), median-score threshold)0.59 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CanDrA on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CanDrA (Chen et al. 2020)Negative predictive value (OncoKB benchmark (positive set not stated), median-score threshold)0.59 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CanDrA on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CanDrA (Chen et al. 2020)Precision (OncoKB benchmark (positive set not stated), median-score threshold)0.59 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CanDrA on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CanDrA (Chen et al. 2020)Recall (OncoKB benchmark (positive set not stated), median-score threshold)0.59 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CanDrA on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CanDrA (Chen et al. 2020)Specificity (OncoKB benchmark (positive set not stated), median-score threshold)0.59 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CanDrA on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CHASM (Chen et al. 2020)Accuracy (cell viability drivers versus neutral, median-score threshold)0.69 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CHASM on cell viability drivers versus neutral, median-score threshold (Chen et al. 2020)
CHASM (Chen et al. 2020)Negative predictive value (cell viability drivers versus neutral, median-score threshold)0.69 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CHASM on cell viability drivers versus neutral, median-score threshold (Chen et al. 2020)
CHASM (Chen et al. 2020)Precision (cell viability drivers versus neutral, median-score threshold)0.69 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CHASM on cell viability drivers versus neutral, median-score threshold (Chen et al. 2020)
CHASM (Chen et al. 2020)Recall (cell viability drivers versus neutral, median-score threshold)0.69 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CHASM on cell viability drivers versus neutral, median-score threshold (Chen et al. 2020)
CHASM (Chen et al. 2020)Specificity (cell viability drivers versus neutral, median-score threshold)0.69 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CHASM on cell viability drivers versus neutral, median-score threshold (Chen et al. 2020)
CHASM (Chen et al. 2020)Accuracy (OncoKB benchmark (positive set not stated), median-score threshold)0.65 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CHASM on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CHASM (Chen et al. 2020)Negative predictive value (OncoKB benchmark (positive set not stated), median-score threshold)0.65 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CHASM on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CHASM (Chen et al. 2020)Precision (OncoKB benchmark (positive set not stated), median-score threshold)0.65 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CHASM on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CHASM (Chen et al. 2020)Recall (OncoKB benchmark (positive set not stated), median-score threshold)0.65 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CHASM on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CHASM (Chen et al. 2020)Specificity (OncoKB benchmark (positive set not stated), median-score threshold)0.64 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CHASM on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CTAT-cancer (Chen et al. 2020)Accuracy (cell viability drivers versus neutral, median-score threshold)0.70 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CTAT-cancer on cell viability drivers versus neutral, median-score threshold (Chen et al. 2020)
CTAT-cancer (Chen et al. 2020)Negative predictive value (cell viability drivers versus neutral, median-score threshold)0.70 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CTAT-cancer on cell viability drivers versus neutral, median-score threshold (Chen et al. 2020)
CTAT-cancer (Chen et al. 2020)Precision (cell viability drivers versus neutral, median-score threshold)0.70 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CTAT-cancer on cell viability drivers versus neutral, median-score threshold (Chen et al. 2020)
CTAT-cancer (Chen et al. 2020)Recall (cell viability drivers versus neutral, median-score threshold)0.70 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CTAT-cancer on cell viability drivers versus neutral, median-score threshold (Chen et al. 2020)
CTAT-cancer (Chen et al. 2020)Specificity (cell viability drivers versus neutral, median-score threshold)0.70 fractionMissense mutations with Ba/F3 and MCF10A cell viability calls (published and new)CTAT-cancer on cell viability drivers versus neutral, median-score threshold (Chen et al. 2020)
CTAT-cancer (Chen et al. 2020)Accuracy (OncoKB benchmark (positive set not stated), median-score threshold)0.63 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CTAT-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CTAT-cancer (Chen et al. 2020)Negative predictive value (OncoKB benchmark (positive set not stated), median-score threshold)0.63 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CTAT-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CTAT-cancer (Chen et al. 2020)Precision (OncoKB benchmark (positive set not stated), median-score threshold)0.63 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CTAT-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CTAT-cancer (Chen et al. 2020)Recall (OncoKB benchmark (positive set not stated), median-score threshold)0.63 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CTAT-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CTAT-cancer (Chen et al. 2020)Specificity (OncoKB benchmark (positive set not stated), median-score threshold)0.63 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CTAT-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)

Claims

Statements this source supports, each with where in the source it was checked.

  • Baseline: Assess somatic small-variant oncogenicity: Baseline ClinGen/CGC/VICC rules (OncoVI) and SIFT (uc-clinical-20260930-source-oncovi: Methods (IF-ELSE implementation of the points-based SOP); somatic-oncogenicity-20261009-source-chen2020: Table 1 (SIFT position-specific scoring matrix) and Introduction (SIFT widely used in cancer research))
  • CADD: description: Description Combined Annotation-Dependent Depletion: a genome-wide variant deleteriousness score that integrates more than 60 genomic features in a machine learning model trained to separate simulated de novo variants from variants fixed in human populations since the human-chimpanzee split. It scores single nucleotide variants and short insertions and deletions anywhere in the reference assembly, not only missense variants. (Record description; cited Rentzsch et al. 2019, Nucleic Acids Research 47:D886)
  • CanDrA: description: Description Scores missense variants with a support vector machine over structural, evolutionary and genomic features together with the scores of published predictors. (somatic-oncogenicity-20261009-source-chen2020: Table 1, Summary of 33 computational algorithms included in this study)
  • CHASM: description: Description Scores missense variants with a random forest over structural, evolutionary and genomic features. (somatic-oncogenicity-20261009-source-chen2020: Table 1, Summary of 33 computational algorithms included in this study)
  • CTAT (cancer and population ensembles): description: Description Scores missense variants with principal-component ensembles of other predictors: the cancer ensemble combines TransFIC, FATHMM, CHASM and CanDrA, and the population ensemble combines SIFT, PolyPhen-2, MutationAssessor and VEST. (somatic-oncogenicity-20261009-source-chen2020: Table 1, Summary of 33 computational algorithms included in this study)
  • DANN: description: Description Scores variants with a deep neural network over conservation, epigenetic signals, the scores of other predictors and genetic context. (somatic-oncogenicity-20261009-source-chen2020: Table 1, Summary of 33 computational algorithms included in this study)
  • DEOGEN2: description: Description Scores missense variants with a random forest over evolutionary, protein, gene and pathway features together with PROVEAN scores. (somatic-oncogenicity-20261009-source-chen2020: Table 1, Summary of 33 computational algorithms included in this study)
  • Eigen: description: Description Scores variants by an unsupervised spectral method that combines the scores of other tools, allele frequencies and epigenomic signals; the paper evaluates both the Eigen and the Eigen-PC variant. (somatic-oncogenicity-20261009-source-chen2020: Table 1, Summary of 33 computational algorithms included in this study)
  • Evidence summary: somatic small-variant oncogenicity: Summary Two predictor comparisons join the existing OncoVI evidence; their values cannot be pooled. In Chen et al. 2020 (peer reviewed), 33 predictors scored somatic missense mutations labelled by OncoKB curation or by the authors' own cell viability assays, with likely neutral or assay-neutral somatic negatives. The authors co-developed one scored tool, CanDrA, and developed none of the others. With each tool's own default calls, the highest accuracy was 0.70 on OncoKB labels (DEOGEN2, sensitivity 0.87, specificity 0.51), and several tools called most neutral mutations damaging, for example M-CAP with sensitivity 0.97 and specificity 0.11, and CanDrA with specificity 0.17 and the lowest accuracy, 0.49. On the assay labels the highest default accuracy was 0.65 (PrimateAI). When each tool's median score on the test draw was used as the threshold, which ranks tools but is not an operating point a reviewer could apply, the highest accuracy was 0.69 on OncoKB labels (PROVEAN and VEST4) and 0.70 on assay labels (CTAT-cancer and PrimateAI), and FATHMM-disease scored 0.50 on OncoKB labels. Chen et al. print each value as a mean with a range of two standard deviations over 100 draws, not a confidence interval, and do not say which OncoKB positive set fed these tables. In a single-author bioRxiv preprint that is not peer reviewed (Lee 2026), 49 scores were compared on Cancer Gene Census missense variants whose negatives are germline-benign labels (ClinVar benign or likely benign, and gnomAD common variants), which this use case does not accept as somatic controls. In that table 42 of the 49 scores had a lower AUROC on oncogene variants than on tumour-suppressor variants, for example AlphaMissense 0.885 against 0.900 and CADD 0.821 against 0.894, while popEVE went the other way (0.900 against 0.842). The highest all-gene AUROC was 0.876 (MutScore); these AUROC values are rounded here to three decimals from the table's full precision. None of these comparisons covers small indels, calibrated probabilities, criterion-level evidence strength, drug response or reviewer agreement. (somatic-oncogenicity-20261009-source-chen2020-additional-file-9 and -10: Benchmark 2; somatic-oncogenicity-20261009-source-chen2020-additional-file-21 and -22: Benchmark 5; somatic-oncogenicity-20261009-source-chen2020: Methods and reference 7; somatic-oncogenicity-20261009-source-lee2026-oncocal-tool-performance: tables/tool_performance.tsv; somatic-oncogenicity-20261009-source-lee2026: Methods and Results)
  • FATHMM-MKL: description: Description Scores variants by multiple kernel learning over conservation and epigenomic signals. (somatic-oncogenicity-20261009-source-chen2020: Table 1, Summary of 33 computational algorithms included in this study)
  • FATHMM-XF: description: Description Scores variants by multiple kernel learning over conservation, genomic features and epigenomic signals. (somatic-oncogenicity-20261009-source-chen2020: Table 1, Summary of 33 computational algorithms included in this study)
  • FATHMM: description: Description Scores missense variants with hidden Markov models over sequence homology; the paper evaluates both the disease-weighted and the cancer-weighted variant. (somatic-oncogenicity-20261009-source-chen2020: Table 1, Summary of 33 computational algorithms included in this study)
  • GenoCanyon: description: Description Scores a position by the posterior probability that it is functional, from unsupervised statistical learning over conservation and biochemical annotation. (somatic-oncogenicity-20261009-source-chen2020: Table 1, Summary of 33 computational algorithms included in this study)
  • Integrated_fitCons: description: Description Scores the fitness consequences of a position by applying the INSIGHT evolutionary model to integrated epigenomic signals. (somatic-oncogenicity-20261009-source-chen2020: Table 1, Summary of 33 computational algorithms included in this study)
  • LRT: description: Description Scores a variant by a likelihood ratio test of codon neutrality from sequence homology. (somatic-oncogenicity-20261009-source-chen2020: Table 1, Summary of 33 computational algorithms included in this study)
  • M-CAP: description: Description Scores missense variants with a gradient-boosted tree classifier over the scores of published predictors and conservation. (somatic-oncogenicity-20261009-source-chen2020: Table 1, Summary of 33 computational algorithms included in this study)
  • MetaLR: description: Description Scores missense variants with a logistic regression over nine prediction scores and 1000 Genomes allele frequencies. (somatic-oncogenicity-20261009-source-chen2020: Table 1, Summary of 33 computational algorithms included in this study)
  • MetaSVM: description: Description Scores missense variants with a radial-kernel support vector machine over nine prediction scores and 1000 Genomes allele frequencies. (somatic-oncogenicity-20261009-source-chen2020: Table 1, Summary of 33 computational algorithms included in this study)
  • MPC: description: Description Scores missense variants with a logistic regression over regional missense constraint, missense badness and PolyPhen-2 scores. (somatic-oncogenicity-20261009-source-chen2020: Table 1, Summary of 33 computational algorithms included in this study)
  • MutationAssessor: description: Description Scores a substitution from sequence homology with a combinatorial entropy formalism. (somatic-oncogenicity-20261009-source-chen2020: Table 1, Summary of 33 computational algorithms included in this study)
  • MutationTaster: description: Description Scores variants with a naive Bayes classifier over conservation, genetic context and regulatory features. (somatic-oncogenicity-20261009-source-chen2020: Table 1, Summary of 33 computational algorithms included in this study)
  • MutPred: description: Description Scores missense variants with a random forest over protein structural and functional properties, conservation and SIFT scores. (somatic-oncogenicity-20261009-source-chen2020: Table 1, Summary of 33 computational algorithms included in this study)
  • MVP: description: Description Scores missense variants with a deep neural network over sequence and structural features, the scores of published predictors and conservation. (somatic-oncogenicity-20261009-source-chen2020: Table 1, Summary of 33 computational algorithms included in this study)
  • PolyPhen-2: description: Description Scores missense variants with a naive Bayes classifier over eight sequence-based and three structure-based features; the paper evaluates both the HumDiv and the HumVar trained variant. (somatic-oncogenicity-20261009-source-chen2020: Table 1, Summary of 33 computational algorithms included in this study)
  • PrimateAI: description: Description Scores missense variants with a deep residual neural network over sequence homology. (somatic-oncogenicity-20261009-source-chen2020: Table 1, Summary of 33 computational algorithms included in this study)

Models, benchmarks and other records

Methods (28)

Configurations (33)

Protocols (4)

Datasets (2)

Evaluations (100)

Use cases (1)

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

17 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-02-a7f03c9e55a5
Property and statementOriginal source and locationReview and provenance
Artifact SHA-256
fef52f70c3a0ff3f82902f87080933c220e12274787de6309b41ee283daf8b8e
Source metadata
Comprehensive assessment of computational algorithms in predicting cancer driver mutations

Original source ↗

No field-specific location recorded

Version: Genome Biology 21:43, published 2020-02-20; PMC7033911 full-text XML
Retrieved: 2026-10-09T20:45:50Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.artifact_sha256

Source artifact SHA-256: fef52f70c3a0ff3f82902f87080933c220e12274787de6309b41ee283daf8b8e

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Artifact url
https://www.ebi.ac.uk/europepmc/webservices/rest/PMC7033911/fullTextXML
Source metadata
Comprehensive assessment of computational algorithms in predicting cancer driver mutations

Original source ↗

No field-specific location recorded

Version: Genome Biology 21:43, published 2020-02-20; PMC7033911 full-text XML
Retrieved: 2026-10-09T20:45:50Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.artifact_url

Source artifact SHA-256: fef52f70c3a0ff3f82902f87080933c220e12274787de6309b41ee283daf8b8e

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Doi
10.1186/s13059-020-01954-z
Source metadata
Comprehensive assessment of computational algorithms in predicting cancer driver mutations

Original source ↗

No field-specific location recorded

Version: Genome Biology 21:43, published 2020-02-20; PMC7033911 full-text XML
Retrieved: 2026-10-09T20:45:50Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.doi

Source artifact SHA-256: fef52f70c3a0ff3f82902f87080933c220e12274787de6309b41ee283daf8b8e

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Licence
CC-BY-4.0
Source metadata
Comprehensive assessment of computational algorithms in predicting cancer driver mutations

Original source ↗

No field-specific location recorded

Version: Genome Biology 21:43, published 2020-02-20; PMC7033911 full-text XML
Retrieved: 2026-10-09T20:45:50Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.licence

Source artifact SHA-256: fef52f70c3a0ff3f82902f87080933c220e12274787de6309b41ee283daf8b8e

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Media type
application/xml
Source metadata
Comprehensive assessment of computational algorithms in predicting cancer driver mutations

Original source ↗

No field-specific location recorded

Version: Genome Biology 21:43, published 2020-02-20; PMC7033911 full-text XML
Retrieved: 2026-10-09T20:45:50Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.media_type

Source artifact SHA-256: fef52f70c3a0ff3f82902f87080933c220e12274787de6309b41ee283daf8b8e

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Publication status
peer_reviewed
Source metadata
Comprehensive assessment of computational algorithms in predicting cancer driver mutations

Original source ↗

No field-specific location recorded

Version: Genome Biology 21:43, published 2020-02-20; PMC7033911 full-text XML
Retrieved: 2026-10-09T20:45:50Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.publication_status

Source artifact SHA-256: fef52f70c3a0ff3f82902f87080933c220e12274787de6309b41ee283daf8b8e

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Retrieved at
2026-10-09T20:45:50Z
Source metadata
Comprehensive assessment of computational algorithms in predicting cancer driver mutations

Original source ↗

No field-specific location recorded

Version: Genome Biology 21:43, published 2020-02-20; PMC7033911 full-text XML
Retrieved: 2026-10-09T20:45:50Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.retrieved_at

Source artifact SHA-256: fef52f70c3a0ff3f82902f87080933c220e12274787de6309b41ee283daf8b8e

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Url
https://doi.org/10.1186/s13059-020-01954-z
Source metadata
Comprehensive assessment of computational algorithms in predicting cancer driver mutations

Original source ↗

No field-specific location recorded

Version: Genome Biology 21:43, published 2020-02-20; PMC7033911 full-text XML
Retrieved: 2026-10-09T20:45:50Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.url

Source artifact SHA-256: fef52f70c3a0ff3f82902f87080933c220e12274787de6309b41ee283daf8b8e

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Version
Genome Biology 21:43, published 2020-02-20; PMC7033911 full-text XML
Source metadata
Comprehensive assessment of computational algorithms in predicting cancer driver mutations

Original source ↗

No field-specific location recorded

Version: Genome Biology 21:43, published 2020-02-20; PMC7033911 full-text XML
Retrieved: 2026-10-09T20:45:50Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.version

Source artifact SHA-256: fef52f70c3a0ff3f82902f87080933c220e12274787de6309b41ee283daf8b8e

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Description
Primary source retrieved and hashed for the somatic oncogenicity use-case pass.
Source metadata
Comprehensive assessment of computational algorithms in predicting cancer driver mutations

Original source ↗

No field-specific location recorded

Version: Genome Biology 21:43, published 2020-02-20; PMC7033911 full-text XML
Retrieved: 2026-10-09T20:45:50Z

catalogued

No individual claim review recorded

Audit details

Field: description

Source artifact SHA-256: fef52f70c3a0ff3f82902f87080933c220e12274787de6309b41ee283daf8b8e

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-02-a7f03c9e55a5 · Record review: source checked

Primary source retrieved and hashed for the somatic oncogenicity use-case pass.

Release history

No supporting source is linked yet.

Read original source

Download this release (gzip)
Technical metadata and extraction receipts

Stable ID: somatic-oncogenicity-20261009-source-chen2020

areas
dna-genomes
contexts
clinical_research
url
https://doi.org/10.1186/s13059-020-01954-z
artifact url
https://www.ebi.ac.uk/europepmc/webservices/rest/PMC7033911/fullTextXML
version
Genome Biology 21:43, published 2020-02-20; PMC7033911 full-text XML
retrieved at
2026-10-09T20:45:50Z
artifact sha256
fef52f70c3a0ff3f82902f87080933c220e12274787de6309b41ee283daf8b8e
doi
10.1186/s13059-020-01954-z
publication status
peer_reviewed
licence
CC-BY-4.0
media type
application/xml
Related records

    Suggest a correction